While an emergency use authorization may be the speediest way for public health officials to begin a vaccination campaign, it may not end up shaving that much time off of a more traditional route to ...

What is an emergency use authorization? An emergency use authorization is a tool that the FDA uses to strengthen the nation’s response to public health emergencies such as COVID-19.

The FDA issued an emergency use authorization to drug-maker Lilly for bamlanivimab, a monoclonal antibody that mimics the immune system’s response to infection with the virus that causes COVID-19.

The first COVID-19 vaccine was distributed under an Emergency Use Authorization. More than seven months later, actual approval hasn’t been granted.

Emergency use authorization can be granted when a vaccine meets certain standards during a time when there is extreme risk to public health.

Until recently, you may have never heard the term “Emergency Use Authorization.” These words entered the lexicon as people around the world anxiously read updates about the COVID-19 pandemic ...

Moderna, Inc. (MRNA) on Thursday announced that the U.S. Food and Drug Administration (FDA) has fully approved its COVID-19 ...

To win emergency use authorization, or EUA, drug or device makers may present the FDA with less evidence of a product’s safety and effectiveness than is required for full approval.

Emergency use authorization can be granted when a vaccine meets certain standards during a time when there is extreme risk to public health.

The emergency use authorization acknowledges that in a time of dire need, the vaccine meets certain requirements to justify its use during the COVID-19 pandemic, including that there are no other ...